Endothelial dysfunction and fetuin A levels before and after kidney transplantation

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Biochemistry

Background:

• Endothelial dysfunction (ED) significantly impacts cardiovascular outcomes in chronic kidney disease (CKD) patients.
• Investigating biomarkers for ED is crucial for managing CKD complications.

Purpose of the Study:

• To explore the association between serum fetuin A levels and endothelial function in kidney transplant recipients.
• To assess changes in endothelial function markers post-transplantation.

Main Methods:

• Study included 42 kidney transplant recipients and 42 healthy controls.
• Measurements included serum fetuin A, hsCRP, FMD, NMD, and CIMT before and after transplantation.
• Recipients were on either cyclosporine A or tacrolimus-based immunosuppression.

Main Results:

• Pre-transplant, patients had lower fetuin A and FMD compared to controls (P<0.001).
• Fetuin A and FMD levels increased significantly post-transplantation (P<0.001).
• Fetuin A positively correlated with FMD (r=0.534 to 0.576, P<0.001); hsCRP and CIMT decreased post-transplant.

Conclusions:

• Low serum fetuin A may contribute to endothelial dysfunction in CKD.
• Fetuin A is an independent determinant of endothelial function (FMD) in kidney transplant recipients.
• Further research is needed to clarify fetuin A's role in CKD cardiovascular outcomes.